Abstract
In this chapter, our purpose is to provide some clues on what can or cannot be expected from gene expression and genetic testing to investigate skin physiopathology using DNA microarrays. The use of these technologies has dramatically increased during the past years, and several studies have been performed for various dermatological diseases, such as malignant melanoma, psoriasis, and lupus erythematosus (reviewed in Kunz et al. (Exp Dermatol 13(10):593–606, 2004)). Identification of key target genes and pathways involved in such diseases provides enormous perspectives for dermatologists. The first section of this chapter will describe the main features of the available DNA microarray technologies and methodologies to be mastered in order to get meaningful data. In the second section, we choose to show how gene expression profiling can contribute to increase our basic knowledge on psoriasis as a case study as well as to identify diagnostic/prognostic markers. In the last section, the impact of combined discoveries issued from the analyses of gene expression and genetic testing based on single nucleotide polymorphism (SNP) in dermatology will be discussed. We hope that the present chapter will provide the basic understanding of these technologies to dermatologists, helping them to deal with the complexity of what is called functional genomics.
If our brains were simple enough for us to understand them, we’d be so simple that we couldn’t. (Ian Stewart, The Collapse of Chaos: Discovering Simplicity in a Complex World)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ainali C, Valeyev N, Perera G, Williams A, Gudjonson JE, Ouzounis CA, Nestle FO, Tsoka S. Transcriptomic classification reveals molecular subtypes in psoriasis. BMC Genomics. 2012;13:472.
Al Robaee AA. Molecular genetics of psoriasis (principles, technology, gene location, genetic polymorphism and gene expression). Int J Health Sci (Qassim). 2010;4(2):103–27.
Barrey E, Mucher E, Jeansoule N, Larcher T, Larcher T, Guigand L, Herszberg B, Chaffaux S, Guerin G, Mata X, Benech P, Canale M, Alibert O, Maltere P, Gidrol X, Barrey E, Mucher E, Jeansoule N, Larcher T. Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions. BMC Vet Res. 2009;5(1):29.
Barrey E, Jayr VL, Mucher E, Gospodnetic S, Joly F, Benech P, Alibert O, Gidrol X, Mata X, Vaiman A, Guerin G. Transcriptomic analysis of muscle in horses suffering from recurrent exertional rhabdomyolysis revealed energetic pathway alterations and disruption in the cytosolic calcium regulation. Anim Genet. 2012;43(3):271–81.
Ben-Bassat H, Klein BY. Inhibitors of tyrosine kinases in the treatment of psoriasis. Curr Pharm Des. 2000;6(9):933–42.
Benech P, Mas-Chamberlin C, Mondon P, Lintner K. PredictSearch: understanding biological activity of cosmetic ingredients. Personal Care Asia September. 2007:61(8):61–65.
Bièche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R. Prognostic value of ERBB family mRNA expression in breast carcinomas. Int J Cancer. 2003;106(5):758–65.
Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001; 10:1793–1805.
Fang S, Fang X, Xiong M. Psoriasis prediction from genome-wide SNP profiles. BMC Dermatol. 2011;11:1.
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531–7.
Gudjonsson JE, Johnston A, Stoll SW, Riblett MB, Xing X, Kochkodan JJ, Ding J, Nair RP, Aphale A, Voorhees JJ, Elder JT. Evidence for altered Wnt signaling in psoriatic skin. J Invest Dermatol. 2010;130(7):1849–59.
Hagforsen E, Sunnerberg K, Michaëlsson G, Kämpe O, Hedstrand H. Psoriasis autoantigens in normal scalp skin – identification by expression cloning. J Invest Dermatol. 2007;127(9):2276–80.
Hand D, Mannila H, Smyth P. Principles of data-mining. Cambridge, MA: The MIT Press; 2001.
Hayward P, Kalmar T, Arias AM. Wnt/Notch signalling and information processing during development. Development. 2008;135(3):411–24.
Hedegaard J, Arce C, Bicciato S, Bonnet A, Buitenhuis B, Collado-Romero M, Conley LN, Sancristobal M, Ferrari F, Garrido JJ, Groenen MA, Hornshøj H, Hulsegge I, Jiang L, Jiménez-Marín A, Kommadath A, Lagarrigue S, Leunissen JA, Liaubet L, Neerincx PB, Nie H, van der Poel J, Prickett D, Ramirez-Boo M, Rebel JM, Robert-Granié C, Skarman A, Smits MA, Sørensen P, Tosser-Klopp G, Watson M. Methods for interpreting lists of affected genes obtained in a DNA microarray experiment. BMC Proc. 2009;3 Suppl 4:S5.
Hu T, Li C. Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer. 2010;9:236.
International HapMap Consortium. The International HapMap Project. Nature. 2003;426:789–96.
Jeffery IB, Higgins DG, Culhane AC. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics. 2006;7:359.
Johnston A, Xing X, Swindell WR, Kochkodan J, Riblett M, Nair RP, Stuart PE, Ding J, Voorhees JJ, Elder JT, Gudjonsson JE. Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis. Hum Mol Genet. 2013;22(9):1807–15.
Jullien D, Barker JN. Genetics of psoriasis. J Eur Acad Dermatol Venereol. 2006;20 Suppl 2:42–51.
Kelder T, Conklin BR, Evelo CT, Pico AR. Finding the right questions: exploratory pathway analysis to enhance biological discovery in large datasets. PLoS Biol. 2010;31:8(8).
Kunz M, Dannemann M, Kelso J. High-throughput sequencing of the melanoma genome. Exp Dermatol. 2013;22(1):10–7.
Kwon EK, Basel D, Siegel D, Martin KL. A review of next-generation genetic testing for the dermatologist. Pediatr Dermatol. 2013;30(4):401–8.
Lander ES. Array of hope. Nat Genet. 1999;21(Suppl):3–4.
Lowell S, Jones P, Le Roux I, Dunne J, Watt FM. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr Biol. 2000;10:491–500.
Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E. Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 2005;19:1596–611.
Martinez Arias A, Stewart A. Molecular principles of animal development. New York: Oxford University Press; 2002.
Mascia F, Mariani V, Girolomoni G, Pastore S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol. 2003;163:303–12.
Mascia F, Cataisson C, Lee TC, Threadgill D, Mariani V, Amerio P, Chandrasekhara C, Souto Adeva G, Girolomoni G, Yuspa SH, Pastore S. EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol. 2010;130(3):682–93.
Mille-Hamard L, Billat VL, Henry E, Bonnamy B, Joly F, Benech P, Barrey E. Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study. BMC Med Genomics. 2012;5(1):29.
Miller LS, Sørensen OE, Liu PT, Jalian HR, Eshttiaghpour D, Behmanesh BE, et al. TGF-α regulates TLR expression and function on epidermal keratinocytes. J Immunol. 2005;174:6137–43.
National Institutes of Health. All about the human genome project internet. Bethesda: National Institutes of Health (2012). http://www.genome.gov/10001772. Accessed 5 Jan 2012.
Nishimoto S, Kotani H, Tsuruta S, Shimizu N, Ito M, Shichita T, Morita R, Takahashi H, Amagai M, Yoshimura A. Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J Immunol. 2013;191(6):3065–72.
Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J.2012;31(12):2670–84.
Oestreicher JL, Walters IB, Kikuchi T, et al. Molecular classification of psoriasis disease-associated DNA microarray technology in dermatology genes through pharmacogenomic expression profiling. Pharmacogenomics J. 2001;1:272–87.
Peterson S. DNA microarrays RNAseq-the winner and new heavyweight champion is?…It’s a draw. Infect Dis Microb Environ Genomics Seq. http://blogs.jcvi.org/2010/02/dna-microarrays-vs-rnaseq-the-winner-and-new-heavyweight-champion-is-it’s-a-draw/. Accessed on 3 Feb 2010.
Pietrzak A, Zalewska A, Chodorowska G, Nockowski P, Michalak-Stoma A, Osemlak P, Krasowska D. Genes and structure of selected cytokines involved in pathogenesis of psoriasis. Folia Histochem Cytobiol. 2008;46(1):11–21.
Rao T, Kühl M. An updated overview on Wnt signaling pathways: a prelude for more. Circ Res. 2010;106:1798–806.
Rees JL, Harding RM. Understanding the evolution of human pigmentation: recent contributions from population genetics. J Invest Dermatol. 2012;132(3 Pt 2):846–53.
Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol. 2005;6:491–500.
Saneczko F, Kaszuba A, Trznadel-BudŸko E. Human leukocyte antigens (HLA) in psoriasis. (Polish). Pol Merk Lek. 1997;3:210–2.
Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467–70.
Shi L, Jones WD, Jensen RV, Harris SC, Perkins RG, et al. The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics. 2008;9 Suppl 9:S10.
Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borrregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol. 2003;170:5583–9.
Suarez-Farinas M, Lowes MA, Zaba LC, Krueger JG. Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analyses (GSEA). PLoS One. 2010;5(4):e10247.
Swindell WR, Johnston A, Voorhees JJ, Elder JT, Gudjonsson JE. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics. 2013;14:527.
Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57–63.
Witten DM, Tibshirani R. A comparison of fold-change and the t-statistic for microarray data analyses. Stanford: Stanford University; 2007. p. 1–13.
Zhang M, Yao C, Guo Z, Zou J, Zhang L, et al. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics. 2008;24:2057–63.
Zhao J, Gupta S, Seielstad M, Liu J, Thalamuthu A. Pathway-based analysis using reduced gene subsets in genome-wide association studies. BMC Bioinformatics. 2011;12:17.
Zhou X, Krueger JG, Kao MC, et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics. 2003;13:69–78.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Benech, P. (2017). Gene Expression and Genetic Evaluation of the Skin. In: Humbert, P., Fanian, F., Maibach, H., Agache, P. (eds) Agache's Measuring the Skin. Springer, Cham. https://doi.org/10.1007/978-3-319-32383-1_126
Download citation
DOI: https://doi.org/10.1007/978-3-319-32383-1_126
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32381-7
Online ISBN: 978-3-319-32383-1
eBook Packages: MedicineReference Module Medicine